---
id: kawasaki-disease_183
category: syndromes
tags: [kawasaki, vasculitis, coronary-aneurysm, ivig, aspirin, pediatric]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Kawasaki Disease

**Q:** What are the diagnostic criteria for Kawasaki disease, coronary artery complications, and treatment (IVIG + aspirin)?

**A:**

## DEFINITION

**Kawasaki Disease (Mucocutaneous Lymph Node Syndrome):**
- **Acute febrile vasculitis** of medium-sized vessels (coronary arteries - PRIMARY target)
- **Most common cause of acquired heart disease** in children (developed countries)
- **Peak age:** 6 months - 5 years (80% <5 years)
- **Etiology:** Unknown (likely infectious trigger + genetic predisposition)

**Key Point:** **Kawasaki = most common acquired heart disease** in children (coronary aneurysms)

---

## DIAGNOSTIC CRITERIA (CLASSIC KAWASAKI)

**Mnemonic: "FEVER-5-DAYS-PLUS-4-OF-CRASH"**

### **Required:**
**Fever ≥5 days** (≥38.3°C / 101°F)

### **PLUS 4 of 5 "CRASH" Criteria:**

**C**onjunctivitis (bilateral, non-exudative)
**R**ash (polymorphous - macular, morbilliform, scarlatiniform)
**A**denopathy (cervical, usually unilateral, >1.5cm)
**S**trawberry tongue / mucositis (cracked lips, oral erythema)
**H**ands and feet (erythema/edema of palms/soles → desquamation)

**Key Point:** **Fever ≥5 days + 4/5 CRASH** = classic Kawasaki

---

## CLINICAL FEATURES (EXPANDED)

**Mnemonic: "CRASH-PLUS-CARDIAC"**

### **1. Conjunctivitis (85-90%):**
- **Bilateral, non-exudative** (bulbar > palpebral)
- **NO discharge** (distinguishes from bacterial conjunctivitis)

### **2. Rash (90%):**
- **Polymorphous:** Macular, morbilliform, scarlatiniform
- **Trunk/extremities** (spares face usually)
- **Appears 1-5 days after fever onset**

### **3. Adenopathy (50-75%):**
- **Cervical, usually unilateral**
- **>1.5cm** (often solitary large node)
- **LEAST common major criterion**

### **4. Strawberry Tongue / Oral Mucositis (90%):**
- **Strawberry tongue** (prominent papillae - resembles scarlet fever)
- **Cracked, fissured lips** (hemorrhagic crusting)
- **Diffuse oral/pharyngeal erythema**
- **NO exudates, vesicles, or ulcers**

### **5. Hands and Feet (70-90%):**
- **Acute phase (days 1-10):**
  - **Erythema** (palms/soles - red, indurated)
  - **Edema** (dorsum of hands/feet - "puffy")
- **Convalescent phase (weeks 2-3):**
  - **Periungual desquamation** (fingertips/toes - CHARACTERISTIC)

**Key Point:** **Periungual desquamation** (weeks 2-3) = CHARACTERISTIC late finding

---

## INCOMPLETE KAWASAKI DISEASE

**Mnemonic: "FEVER-5-DAYS-PLUS-2-3-CRASH"**

### **Criteria:**
- **Fever ≥5 days**
- **2-3 of CRASH criteria** (NOT all 4)
- **PLUS:**
  - **CRP ≥3mg/dL OR ESR ≥40mm/hr**
  - **Echo showing coronary abnormalities**

### **Who to Consider:**

**High-Risk Groups for Incomplete Kawasaki:**
- **Infants <6 months** (50% present with incomplete)
- **Adolescents/adults** (atypical presentations)

**Key Point:** **Infants <6 months = 50% incomplete** (high risk for coronary aneurysms)

---

## CORONARY ARTERY COMPLICATIONS

**Mnemonic: "ANEURYSM-MI-STENOSIS"**

### **Coronary Artery Aneurysms (CAA):**

**Incidence:**
- **Untreated:** 20-25% (develop CAA)
- **Treated with IVIG <10 days:** 3-5% (85% risk reduction)

**Timing:** **Develops weeks 2-4** (after fever onset)

**Classification (by Internal Diameter):**
- **Small:** <5mm
- **Medium:** 5-8mm
- **Giant:** >8mm (highest risk for thrombosis, MI, death)

**Risk Factors for CAA:**
- **Male** (3:2 male:female)
- **<1 year or >8 years** (extremes of age)
- **Asian ethnicity** (especially Japanese)
- **Delayed treatment** (>10 days after fever onset)
- **IVIG-resistant** (persistent fever after IVIG)
- **Elevated CRP, ESR, proBNP**

**Key Point:** **Untreated = 20-25% CAA** | **IVIG <10 days = 3-5% CAA** (85% reduction)

---

### **Long-Term Complications:**

**Giant Aneurysms (>8mm):**
- **Thrombosis** → **myocardial infarction** (MI - can occur years later)
- **Stenosis** (scar tissue → coronary stenosis)
- **Mortality:** 1-2% (mostly from MI)

**Key Point:** **Giant aneurysms (>8mm) = highest risk** for thrombosis, MI, death

---

## TREATMENT

**Mnemonic: "IVIG-PLUS-ASPIRIN-WITHIN-10-DAYS"**

### **IVIG (Intravenous Immunoglobulin):**

**Dose:** **2g/kg IV** (single infusion over 10-12 hours)

**Timing:** **Within 10 days of fever onset** (ideally within 7 days)
- **After 10 days:** Still beneficial if ongoing inflammation (elevated CRP/ESR)

**Efficacy:**
- **Reduces CAA risk:** From 20-25% → 3-5%
- **Reduces fever duration**
- **Reduces systemic inflammation**

**Key Point:** **IVIG 2g/kg within 10 days** (reduces CAA from 20-25% → 3-5%)

---

### **Aspirin:**

**High-Dose (Anti-Inflammatory):**
- **Dose:** **80-100mg/kg/day PO divided QID** (max 4g/day)
- **Duration:** Until **afebrile x 48-72 hours** (typically 5-7 days)

**Low-Dose (Antiplatelet):**
- **Dose:** **3-5mg/kg/day PO daily** (single dose)
- **Duration:**
  - **No CAA:** Continue x **6-8 weeks** → stop
  - **Small CAA (<5mm):** Continue x **3-12 months** (until aneurysm regresses)
  - **Medium/Giant CAA (≥5mm):** Continue **indefinitely** + anticoagulation (if giant)

**Key Point:** **High-dose aspirin until afebrile** → **low-dose x 6-8 weeks** (if no CAA)

---

### **Anticoagulation (If Giant Aneurysms):**

**Giant CAA (>8mm):**
- **Low-dose aspirin 3-5mg/kg/day**
- **PLUS**
- **Warfarin** (INR 2-2.5) OR **LMWH** (enoxaparin)
- **Duration:** Indefinite (thrombosis risk)

**Key Point:** **Giant CAA (>8mm) = aspirin + warfarin** (indefinite)

---

## IVIG-RESISTANT KAWASAKI (10-20%)

**Definition:** **Persistent/recrudescent fever ≥36 hours after IVIG completion**

**Risk Factors:**
- **Age <1 year**
- **Male**
- **CRP >100mg/L, ESR >80mm/hr**
- **Elevated proBNP**
- **Hypoalbuminemia, hyponatremia**

### **Treatment Options:**

**First-Line:**
1. **Repeat IVIG:** 2g/kg IV (second dose)

**Second-Line (If Still Febrile After 2nd IVIG):**
2. **Methylprednisolone:** 30mg/kg IV daily x 3 days (pulse dose)
3. **Infliximab:** 5mg/kg IV (single dose) - TNF-alpha inhibitor
4. **Anakinra:** IL-1 receptor antagonist (off-label)

**Key Point:** **IVIG-resistant = 10-20%** | **Repeat IVIG first** → **methylprednisolone or infliximab**

---

## LABORATORY FINDINGS

**Mnemonic: "INFLAMMATORY-MARKERS-ELEVATED"**

**Acute Phase (Days 1-10):**
- **Elevated CRP, ESR** (100%)
- **Leukocytosis** (WBC 15,000-30,000 with left shift)
- **Thrombocytosis** (platelets >450,000 - peaks week 2-3)
- **Hypoalbuminemia**
- **Hyponatremia**
- **Elevated transaminases** (ALT/AST - 40%)
- **Sterile pyuria** (50% - WBCs in urine without bacteria)

**Convalescent Phase (Weeks 2-3):**
- **Thrombocytosis** (platelets >1,000,000 - risk of thrombosis if giant CAA)

**Key Point:** **Thrombocytosis peaks week 2-3** (>1,000,000 possible) | **Sterile pyuria = 50%**

---

## ECHOCARDIOGRAPHY

**Timing:**
- **At diagnosis** (baseline)
- **Week 2** (detect early aneurysms)
- **Week 6-8** (reassess)
- **If abnormal:** Serial echo every 1-3 months (until regressed)

**Findings:**
- **Coronary artery dilation/aneurysms** (LAD, RCA, left main - any vessel)
- **Decreased LV function** (myocarditis - transient)
- **Mitral/aortic regurgitation** (valvulitis)
- **Pericardial effusion**

**Key Point:** **Echo at diagnosis, week 2, week 6-8** (detect aneurysms early)

---

## DIFFERENTIAL DIAGNOSIS

**Mnemonic: "SCARLET-STEVEN-TOXIC-MEASLES"**

**Mimics Kawasaki:**
1. **Scarlet fever** (GAS - exudative pharyngitis, NOT in Kawasaki)
2. **Staphylococcal scalded skin syndrome** (SSSS - exfoliative, NOT mucosal)
3. **Toxic shock syndrome** (TSS - hypotension, multi-organ failure)
4. **Measles** (cough, coryza, Koplik spots)
5. **Stevens-Johnson syndrome** (mucosal ulceration/vesicles, skin detachment)
6. **Drug reaction** (recent medication)
7. **Viral exanthem** (adenovirus, EBV)

**Key Distinguishing Features:**
- **Kawasaki:** NO exudates (throat, conjunctiva), NO ulcers/vesicles, conjunctivitis non-exudative
- **Scarlet fever:** Exudative pharyngitis (distinguishes from Kawasaki)

**Key Point:** **NO exudates, vesicles, ulcers** (distinguishes Kawasaki from infectious mimics)

---

**Clinical Pearls:**
- **Kawasaki = most common acquired heart disease** in children (coronary aneurysms)
- **Fever ≥5 days + 4/5 CRASH** = classic Kawasaki
- **CRASH:** Conjunctivitis, Rash, Adenopathy, Strawberry tongue, Hands/feet
- **Periungual desquamation** (weeks 2-3) = CHARACTERISTIC late finding
- **Infants <6 months = 50% incomplete** (high risk for aneurysms)
- **Untreated = 20-25% CAA** | **IVIG <10 days = 3-5% CAA** (85% reduction)
- **IVIG 2g/kg within 10 days** (reduces CAA dramatically)
- **High-dose aspirin until afebrile** → **low-dose x 6-8 weeks** (if no CAA)
- **Giant CAA (>8mm) = aspirin + warfarin** (indefinite - thrombosis risk)
- **IVIG-resistant = 10-20%** | **Repeat IVIG** → **methylprednisolone or infliximab**
- **NO exudates, vesicles, ulcers** (distinguishes from scarlet fever, SJS)
- **Echo at diagnosis, week 2, week 6-8** (detect aneurysms early)

**Media:**

**Additional Resources:**
- **AHA Guidelines:** Kawasaki disease diagnosis and treatment
- **AAP Red Book:** Kawasaki disease
- **UpToDate:** Kawasaki disease

**Sources:** [AHA Kawasaki Guidelines], [AAP Red Book], [UpToDate Kawasaki]
